"Interleukin-11" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lymphohematopoietic cytokine that plays a role in regulating the proliferation of ERYTHROID PRECURSOR CELLS. It induces maturation of MEGAKARYOCYTES which results in increased production of BLOOD PLATELETS. Interleukin-11 was also initially described as an inhibitor of ADIPOGENESIS of cultured preadipocytes.
| Descriptor ID |
D017370
|
| MeSH Number(s) |
D12.644.276.374.465.511 D12.776.467.374.465.511 D23.529.374.465.511
|
| Concept/Terms |
Interleukin-11- Interleukin-11
- Interleukin 11
- IL-11
- IL11
- Adipogenesis Inhibitory Factor
- Factor, Adipogenesis Inhibitory
- Inhibitory Factor, Adipogenesis
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-11".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-11".
This graph shows the total number of publications written about "Interleukin-11" by people in this website by year, and whether "Interleukin-11" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-11" by people in Profiles.
-
Critical role of interleukin-11 in isoflurane-mediated protection against ischemic acute kidney injury in mice. Anesthesiology. 2013 Dec; 119(6):1389-401.
-
IL-11 is required for A1 adenosine receptor-mediated protection against ischemic AKI. J Am Soc Nephrol. 2013 Oct; 24(10):1558-70.
-
Interleukin-11 protects against renal ischemia and reperfusion injury. Am J Physiol Renal Physiol. 2012 Oct 15; 303(8):F1216-24.
-
AP-1 transcription factors, mucin-type molecules and MMPs regulate the IL-11 mediated invasiveness of JEG-3 and HTR-8/SVneo trophoblastic cells. PLoS One. 2012; 7(1):e29745.
-
Treatment of drug-induced thrombocytopenia. Expert Opin Drug Saf. 2002 Jul; 1(2):173-80.
-
Inhibition of the acute-phase response in vivo by anti-gp130 monoclonal antibodies. Br J Haematol. 1996 Dec; 95(3):443-51.